Kobra Rostamizadeh Selected Research

Cysts

11/2018

Efficiency of flubendazole-loaded mPEG-PCL nanoparticles: A promising formulation against the protoscoleces and cysts of Echinococcus granulosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kobra Rostamizadeh Research Topics

Disease

14	Neoplasms (Cancer) 03/2024 - 05/2014
4	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2019
3	Colonic Neoplasms (Colon Cancer) 12/2022 - 02/2018
2	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2021
2	Hemolysis 08/2020 - 11/2018
1	Infections 01/2023
1	Weight Loss (Weight Reduction) 01/2022
1	Echinococcosis (Hydatid Cysts) 12/2021
1	Memory Disorders (Memory Loss) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 07/2019
1	HIV Infections (HIV Infection) 05/2019
1	Malaria 01/2019
1	Cysts 11/2018
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2017

Drug/Important Bio-Agent (IBA)

7	methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA 01/2023 - 02/2018
5	CurcuminIBA 03/2024 - 12/2014
4	polycaprolactoneIBA 01/2023 - 02/2018
4	Ethylene Glycol (Monoethylene Glycol)IBA 01/2023 - 02/2018
4	MicellesIBA 07/2019 - 12/2014
3	didodecyldimethylammoniumIBA 12/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 12/2022 - 01/2021
3	LipidsIBA 03/2022 - 01/2019
2	QuercetinIBA 10/2023 - 12/2022
2	IntegrinsIBA 12/2022 - 02/2018
2	regorafenibIBA 12/2022 - 01/2021
2	monomethoxypolyethylene glycol (MPEG)IBA 12/2022 - 01/2021
2	dimethyldioctadecylammonium (dimethyldioctadecylammonium chloride)IBA 03/2022 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 03/2016
2	Methotrexate (Mexate)FDA LinkGeneric 05/2021 - 01/2019
2	Therapeutic UsesIBA 01/2021 - 03/2019
2	Protons (Proton)IBA 08/2020 - 11/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 05/2014
1	SeleniumIBA 03/2024
1	AlginatesIBA 03/2024
1	Valine (L-Valine)FDA Link 10/2023
1	Rivastigmine (Exelon)FDA LinkGeneric 10/2023
1	AntigensIBA 01/2023
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2023
1	VaccinesIBA 01/2023
1	LycopeneIBA 03/2022
1	Lipid NanoparticlesIBA 03/2022
1	Insulin (Novolin)FDA Link 03/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2022
1	LigandsIBA 03/2022
1	Insulin-Like PeptidesIBA 03/2022
1	PolymersIBA 01/2022
1	Albendazole (Albenza)FDA Link 12/2021
1	ProdrugsIBA 05/2021
1	caprolactoneIBA 01/2021
1	GlucosidesIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	SolutionsIBA 01/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2019
1	Indinavir (Crixivan)FDA Link 05/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2019
1	Drug CombinationsIBA 03/2019
1	flubendazoleIBA 11/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018
1	pyruvate dehydrogenase kinase 4IBA 02/2018
1	NanogelsIBA 08/2017
1	Contrast MediaIBA 03/2016
1	Drug CarriersIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 12/2014

Therapy/Procedure

6	Therapeutics 03/2024 - 03/2016
1	Drug Therapy (Chemotherapy) 12/2022
1	Precision Medicine 03/2016